DR. MEREDITH PAIGE GILSON M.D. NPI 1528058781

NPI Details

DR. Meredith Paige Gilson, M.D. is a family medicine in Bourne, MA with 27 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Meredith Paige Gilson, M.D. NPI is 1528058781. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Graduation Year:1999

The provider's business location address is:

2 TECHNOLOGY PARK DR
SUITE A
BOURNE, MA
ZIP 02532-341
Phone: (508) 743-9543
Fax: (508) 743-8335

The NPI 1528058781 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Hemoglobin a1c level (HCPCS:83036)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood creatinine level (HCPCS:82565)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Urine microalbumin (protein) level (HCPCS:82043)
• Vitamin d-3 level (HCPCS:82306)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Liver enzyme (sgot), level (HCPCS:84450)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Blood potassium level (HCPCS:84132)
• Automated urinalysis test (HCPCS:81003)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Phosphate level (HCPCS:84100)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Iron level (HCPCS:83540)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Bacterial colony count, urine (HCPCS:87086)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Blood sodium level (HCPCS:84295)
• Calcium level, total (HCPCS:82310)
• Blood glucose (sugar) level (HCPCS:82947)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Folic acid level, serum (HCPCS:82746)
• Magnesium level (HCPCS:83735)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Removal of impacted ear wax (HCPCS:69210)
• Ferritin (blood protein) level (HCPCS:82728)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) (HCPCS:80051)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)
• Testing for presence of drug, read by direct observation (HCPCS:80305)

The enumeration date for this NPI number is 10/27/2005 and was last updated on 4/15/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.